The Selebrek® CTO Balloon Dilatation Catheter (CTO catheter) was recently approved by US FDA. This is the third FDA 510(K) certificate for Kossel coronary products after PTCA balloon dilatation catheter and NC PTCA balloon dilatation catheter, which marks that CTO balloon has gained the entrance ticket to enter the American market and enhances the international competitiveness of Kossel coronary products!

Product Introduction
CTO balloon catheters are used to dilate the stenosis of the main or collateral coronary artery (including chronic complete occlusion) through a Minimally invasive interventional procedure (percutaneous intravascular coronary angioplasty PTCA) and improve myocardial blood supply.

Product Features
The diameter of the tip entrance can reach 0.016”.
Minimum balloon profile can reach 0.024”.
The design of a single marker band effectively increases the balloon’s passability.
The spiral cutting design of hypotube effectively enhances the pushing ability of the catheter.